ARTICLE | Company News
Arena, Merck deal
August 8, 2005 7:00 AM UTC
ARNA received a $2 million milestone payment from MRK under a 2002 deal to develop compounds against GPCR targets involved in cardiovascular disease (see BioCentury, Oct. 21, 2002). The payment was tr...